Patents by Inventor Simone Domenico Guglielmetti

Simone Domenico Guglielmetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240050497
    Abstract: Use of a composition comprising bacteria to increase the intestinal production of butyric acid, folic acid or niacin and/or to decrease the intestinal production of succinic acid. Moreover, the present invention relates to the use of said composition for the treatment and/or prevention of an intestinal butyrate- and/or succinate-dependent pathological condition. In particular, for the treatment and/or the prevention of intestinal inflammation, diarrhoea, ulcerative colitis or intestinal colopathies.
    Type: Application
    Filed: October 24, 2023
    Publication date: February 15, 2024
    Inventors: Simone Domenico GUGLIELMETTI, Ruggero ROSSI, Walter FIORE, Andrea BIFFI
  • Patent number: 11839634
    Abstract: The present invention relates to the use of a composition comprising bacteria to increase the intestinal production of butyric acid, folic acid or niacin and/or to decrease the intestinal production of succinic acid. Moreover, the present invention relates to the use of said composition for the treatment and/or prevention of an intestinal butyrate- and/or succinate-dependent pathological condition. In particular, for the treatment and/or the prevention of intestinal inflammation, diarrhoea, ulcerative colitis or intestinal colopathies.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: December 12, 2023
    Assignee: ALFASIGMA S.P.A.
    Inventors: Simone Domenico Guglielmetti, Ruggero Rossi, Walter Fiore, Andrea Biffi
  • Patent number: 11591416
    Abstract: The present invention refers to exopolysaccharide molecules, conditioned media or compositions comprising said molecules or media. Moreover, the present invention refers to use of said exopolysaccharide molecules, conditioned media or compositions as prebiotic, preferably to boost immune system.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: February 28, 2023
    Assignee: SOFAR S.P.A.
    Inventors: Andrea Biffi, Ruggero Rossi, Walter Fiore, Simone Domenico Guglielmetti, Silvia Balzaretti
  • Publication number: 20220313753
    Abstract: The present invention relates to a bacterial strain of Bifidobacterium bifidum MIMBb23 sg (=BbfIBSCM) DSM 32708, compositions comprising said bacterial strain and the use thereof in methods for the treatment of gastrointestinal disorders, in particular functional gastrointestinal disorders, such as, for example, irritable bowel syndrome (IBS) or inflammatory bowel diseases (IBDs).
    Type: Application
    Filed: July 8, 2020
    Publication date: October 6, 2022
    Inventors: Simone Domenico GUGLIELMETTI, Valentina TAVERNITI, Andrea BIFFI, Walter FIORE
  • Publication number: 20190345268
    Abstract: The present invention refers to exopolysaccharide molecules, conditioned media or compositions comprising said molecules or media. Moreover, the present invention refers to use of said exopolysaccharide molecules, conditioned media or compositions as prebiotic, preferably to boost immune system.
    Type: Application
    Filed: December 1, 2017
    Publication date: November 14, 2019
    Inventors: Andrea BIFFI, Ruggero ROSSI, Walter FIORE, Simone Domenico GUGLIELMETTI, Silvia BALZARETTI
  • Publication number: 20160348155
    Abstract: The present invention relates to a method for determining the probiotic/paraprobiotic activity of a composition comprising microorganisms, in particular bacteria, said method being based on evaluating, by metagenomic analysis, the qualitative and/or quantitative change in faecal microbiota following intake of the composition. Moreover, the present invention relates to a kit for carrying out said method.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 1, 2016
    Inventors: Simone Domenico GUGLIELMETTI, Ruggero ROSSI, Walter FIORE, Andrea BIFFI
  • Publication number: 20160296569
    Abstract: The present invention relates to the use of a composition comprising bacteria to increase the intestinal production of butyric acid, folic acid or niacin and/or to decrease the intestinal production of succinic acid. Moreover, the present invention relates to the use of said composition for the treatment and/or prevention of an intestinal butyrate- and/or succinate-dependent pathological condition. In particular, for the treatment and/or the prevention of intestinal inflammation, diarrhoea, ulcerative colitis or intestinal colopathies.
    Type: Application
    Filed: September 5, 2014
    Publication date: October 13, 2016
    Inventors: Simone Domenico GUGLIELMETTI, Ruggero ROSSI, Walter FIORE, Andrea BIFFI
  • Patent number: 9072754
    Abstract: The present disclosure relates to a process for pre-treating raw propolis comprising at least one allergenic activity substance, which comprises reacting propolis with a probiotic microorganism containing one or more cinnamoyl-esterase activity enzymes to obtain a semisolid propolis derivative substantially without or impoverished of allergenic substances. The present invention also relates to a method of purifying semisolid propolis derivative to obtain a hydroalcoholic hydrodispersible propolis derivative.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: July 7, 2015
    Assignee: MR. GIUSEPPE MARIA RICCHIUTO
    Inventors: Giuseppe Maria Ricchiuto, Claudio Sebastiano Gardana, Simone Domenico Guglielmetti
  • Publication number: 20130006011
    Abstract: The present disclosure relates to a process for pre-treating raw propolis comprising at least one allergenic activity substance, which comprises reacting propolis with a probiotic microorganism containing one or more cinnamoyl-esterase activity enzymes to obtain a semisolid propolis derivative substantially without or impoverished of allergenic substances. The present invention also relates to a method of purifying semisolid propolis derivative to obtain a hydroalcoholic hydrodispersible propolis derivative.
    Type: Application
    Filed: March 15, 2011
    Publication date: January 3, 2013
    Inventors: Giuseppe Maria Ricchiuto, Claudio Sebastiano Gardana, Simone Domenico Guglielmetti